Arnold C. Hanish - Nov 20, 2025 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role: Director
Signature: /s/Mark Rosenblum, as Attorney-in-Fact
Stock symbol: SLRX
Transactions as of: Nov 20, 2025
Transactions value $: $3,741
Form type: 4
Date filed: 11/24/2025, 05:08 PM
Previous filing: Jul 1, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
HANISH ARNOLD C	Director	C/O SALARIUS PHARMACEUTICALS, INC., 2450 HOLCOMBE BLVD., SUITE X, HOUSTON	/s/Mark Rosenblum, as Attorney-in-Fact	2025-11-24	0001233253

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLRX	Common Stock	Purchase	$3.74K	+5K	+33333.33%	$0.75	5.02K	Nov 20, 2025	By Arnold C. Hanish Trust	F1
holding	SLRX	Common Stock						12	Nov 20, 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7437 to $0.75, inclusive. The reporting person undertakes to provide to Salarius Pharmaceuticals, Inc., any security holder of Salarius Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7437 to $0.75, inclusive. The reporting person undertakes to provide to Salarius Pharmaceuticals, Inc., any security holder of Salarius Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.